Modone

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Modone

Property Description
Active ingredient Domperidone
Form Oral tablets, Suspension; Rectal suppositories
Pharmacological class Dopamine Antagonist, Prokinetic Drug
General Purpose Relief of nausea and vomiting symptoms, and enhancement of stomach emptying
Origin Synthetic organic compound

What Type of Medicine is Modone (Domperidone)?

Modone is a pharmaceutical product containing Domperidone as its single active ingredient, which belongs to the distinct pharmacological class of Dopamine Antagonists and is formally categorized as a Prokinetic drug. This medicine is a synthetic organic compound, engineered to influence the body’s involuntary muscular movements within the digestive system. The compound functions as a dopamine antagonist that selectively blocks peripheral D2 receptors. The key takeaway for patients is that this blocking action is essential for controlling the signals that trigger the feeling of sickness.

As a Prokinetic drug, the primary function of Domperidone is defined by its ability to modulate and enhance the natural wave-like contractions, or peristalsis, of the muscles in the stomach and esophagus.

The Core Function and Forms of a Prokinetic Drug

The general therapeutic purpose of Modone is to help alleviate symptoms related to slow gastrointestinal movement, including feelings of nausea and the urge to vomit. Domperidone's action improves upper gastrointestinal motility. The medicine is clinically recognized for effectively aiding in moving stomach contents forward to achieve quicker relief from digestive discomfort, such as the persistent feeling of fullness or abdominal distress.

Modone is available in common oral dosage form(s), such as tablets and oral suspensions, which provide flexible options for intake. The high-level composition of these forms involves the active Domperidone, typically as Domperidone Maleate, combined with excipients required for the chosen administration route.

Key Distinction: Peripherally Selective Action

A critical differentiating feature of Domperidone is its peripherally selective action. This means the compound is engineered to primarily target dopamine receptors located outside the central nervous system, minimizing its passage across the blood-brain barrier at therapeutic doses. This focus is crucial, as it allows the medicine to concentrate its effect on the chemoreceptor trigger zone and the gut, maximizing its intended benefit on the digestive system while avoiding the central nervous system effects associated with some other dopamine antagonists.

Regulatory References

  1. EMA's Domperidone Review
  2. NIH LactMed: Domperidone

What side effects are possible with Modone?

Possible Side Effects and Safety Information

Modone has a documented safety profile established through regulatory review, which includes a range of adverse reactions and significant warnings that require careful consideration.

Common Adverse Reactions

Adverse events reported most frequently in clinical studies often involve the central nervous system and gastrointestinal system. The most common adverse reactions include headache, nausea, anxiety, nervousness, dizziness, diarrhea, and difficulty sleeping (insomnia).

Serious and Clinically Significant Adverse Reactions

The most significant safety concerns include the risk of severe, life-threatening skin rashes, such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). These reactions may develop within the first month of treatment but can occur later.

Additional serious risks involve psychiatric symptoms, including new-onset or worsening anxiety, depression, mania, hallucinations, or suicidal ideation. Cardiovascular effects, such as chest pain, hypertension, and palpitations, have also been reported and require careful monitoring.

Safety Considerations and Limitations

Modone is associated with a potential for misuse and dependence, similar to other CNS-active agents, and must be used exactly as prescribed. The label includes warnings regarding multi-organ hypersensitivity reactions and advises that use should be stopped at the first sign of a rash or other sign of an allergic reaction. Caution is advised when prescribing for individuals with a history of psychosis, depression, or cardiac abnormalities.

The full prescribing information contains detailed sections on contraindications, warnings, and precautions, which must be consulted by healthcare professionals for comprehensive risk management.

Overdose and Emergency Response

Regulatory documentation identifies specific clinical manifestations that may occur following an overdose. The documented presentation includes Central Nervous System (CNS) effects such as the presence of unusual, slowed, or uncontrollable movements of the body. Severe cases may result in loss of consciousness or the occurrence of convulsive seizures.

A significant concern highlighted in official labeling is the potential for Neuroleptic Malignant Syndrome (NMS), which is described as a potentially fatal symptom complex. Clinical signs of NMS include marked hyperpyrexia (high fever), severe muscle rigidity, and evidence of autonomic instability such as irregular pulse or blood pressure.

The official guidance mandates that emergency medical attention must be sought immediately if an overdose is suspected. Urgent medical services should be contacted without delay if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. Management procedures are restricted to intensive symptomatic treatment and continuous medical monitoring, as the official labeling does not specify a known antidote. Furthermore, official warnings note an increased risk of death in older adult patients (65 and older) with dementia-related psychosis treated with this class of medication.

Therapeutic Uses of Modone

Quick Facts About Modone

  • Approved Use 1: Management of schizophrenia.
  • Approved Use 2: Management of acute manic and mixed episodes associated with bipolar disorder.
  • Approved Use 3: Adjunctive maintenance treatment of bipolar I disorder.

What Modone Treats: Main Uses and Benefits

Modone is a medication approved for use in the management of specific psychiatric conditions. It is indicated for the management of schizophrenia, a condition affecting thought processes and behavior. The medication is indicated for both newly hospitalized and chronically hospitalized patients with acute illness.

Modone is also approved for the treatment of acute manic and mixed episodes associated with bipolar disorder, which may occur with or without psychotic features. Furthermore, it is approved as an adjunctive therapy for the maintenance treatment of bipolar I disorder in adults, where it is used alongside other standard mood stabilizers. This medication is part of an overall management plan designed to stabilize mood and help control symptoms associated with the condition. Patients should consult their prescribing physician for a full assessment of its therapeutic role in their individual care plan.

Eligibility and Restrictions for Use

Methadone is contraindicated (must not be used) in several patient populations, based strictly on authoritative government regulatory labeling:

Classification Restricted Populations
Absolute Contraindications Significant respiratory depression; acute or severe bronchial asthma in an unmonitored setting; known or suspected gastrointestinal obstruction (including paralytic ileus); known hypersensitivity to the drug or its components.
Restricted/Conditional Use Patients with risk factors for QT interval prolongation or cardiac conduction abnormalities; individuals who are elderly, cachectic, or debilitated; patients with severe Chronic Obstructive Pulmonary Disease (COPD) or decreased respiratory reserve; and those with moderate to severe hepatic or renal impairment.

Age-Related Eligibility

The safety and effectiveness for use in pediatric patients (under 18 years) for pain management are generally not established due to limited clinical data. Elderly patients require caution and reduced starting doses due to increased susceptibility to respiratory depression and potential for reduced organ function.

Pregnancy and Lactation

Methadone is often the recommended treatment for opioid-dependent pregnant women, as maternal use in utero is not associated with birth defects. However, chronic use may result in Neonatal Opioid Withdrawal Syndrome (NOWS) in the newborn. Breastfeeding is generally encouraged for mothers stable on methadone, as the amount excreted in milk is low, though infant monitoring is required.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents emphasize specific drug-drug and drug-substance interactions based on metabolic pathways and pharmacodynamic effects. Co-administration is formally contraindicated with several categories of medicines.

Interaction Classifications (High-Level)

Interaction Severity Classification Regulatory Basis
Contraindicated Combinations EMA/National Agencies
Use-With-Caution Combinations EMA/National Agencies

Resulting Interaction Structure

  • Prohibited Metabolic Combinations: Co-administration with potent CYP3A4 inhibitors is strictly contraindicated. These include systemic azole antifungals (e.g., ketoconazole, fluconazole), macrolide antibiotics (e.g., erythromycin, clarithromycin), and protease inhibitors (e.g., saquinavir). This restriction is due to the documented inhibition of CYP3A4-mediated metabolism, which significantly increases Modone's plasma concentration and systemic exposure.
  • Prohibited Cardiac Combinations: Co-administration with medicines known to prolong the QTc interval is strictly contraindicated. This prohibition addresses the risk of additive pharmacodynamic cardiac effects, which may heighten the potential for serious ventricular arrhythmias.
  • Gastrointestinal Absorption Interference: Antacids or antisecretory agents are documented to reduce the oral bioavailability of Modone. These substances must not be taken simultaneously with Modone.
  • Population-Specific Notes: The interaction risk is officially heightened in patients with moderate or severe hepatic impairment, making this patient population a contraindication for Modone due to reduced drug clearance. A higher risk has also been observed in patients over 60 years of age when concurrently taking interacting medicines.

Regulatory documents define the product's interaction structure primarily through mandatory prohibitions: one based on metabolic inhibition (CYP3A4) resulting in increased exposure, and one based on additive pharmacodynamic cardiac risk (QTc prolongation).

Mechanism of Action

Targeting the Peripheral D2 Receptors and Emetic Signaling

The primary mechanism involves the competitive blockade (antagonism) of Dopamine D2 receptors, mainly in the gastrointestinal tract and the Chemoreceptor Trigger Zone (CTZ). This peripheral action interrupts emetic signal transduction, preventing the CTZ from relaying chemical stimuli to the brain’s vomiting center. This highly selective action engages mechanisms that modulate peripheral dopaminergic signaling.


Disinhibition of Prokinetic Pathways in the Gut

In the stomach and small intestine, dopamine acts as an inhibitor on the muscles' natural movement by suppressing the release of acetylcholine, the key neurotransmitter for contraction. By blocking D2 receptors here, Modone lifts this inhibition—a process called disinhibition—which functionally enhances the cholinergic pathway. This leads to coordinated and accelerated peristalsis and gastric emptying, impacting the signaling dynamic within targeted upper GI pathways.


Understanding Mechanistic Constraints

The prokinetic mechanism is physiologically constrained: the action is weaker if the cholinergic pathway is simultaneously blocked by other agents (anticholinergics). Furthermore, high plasma concentrations may trigger an off-target interaction by inhibiting cardiac Nav1.5 sodium channels, an effect that influences heart electrophysiology.

Dosage and Administration Information

Modone (methadone) is for oral administration only and must be used exactly as prescribed, without increasing the dose or frequency, which can lead to accumulation due to its long half-life.

Administration Scope

Instruction Domain Standard Guidance
Route of Administration For oral use only (tablet, dispersible tablet, or solution). Must not be injected.
Dosing Schedule Initial doses are typically small (e.g., 2.5 mg every 8 to 12 hours for pain in non-opioid tolerant patients, or 20-30 mg once daily for treatment programs). Dose adjustments must be made slowly, generally with an interval of at least 3 to 5 days, because the full effect is delayed.
Preparation Requirements Dispersible tablets must be dissolved in a minimum of 120 mL (4 ounces) of water, orange juice, or a citrus drink and the entire mixture must be consumed immediately. Liquid solutions must be measured using a graduated oral syringe or cup, not a household spoon.
Missed Dose Rule If a dose for long-term treatment is missed, do not take a double dose. Take the next dose at the regularly scheduled time.
Age-Group Rules Dose selection for elderly patients should be cautious, typically starting at the low end of the dosing range. Use in children requires a healthcare provider's determination of the appropriate dose.

These instructions establish the parameters for Modone's use, governing the preparation of the correct form and the schedule for ingestion and dose changes. The slow titration schedule ensures that the medicine is used in alignment with its pharmacokinetic properties to manage the risk of systemic drug accumulation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Modone

Evidence for Acute Nausea and Vomiting

Research has examined Modone in the context of acute nausea and vomiting symptoms in adults and adolescents. The primary research for this indication consisted of Short-term Randomized Controlled Trials (RCTs) and subsequent regulatory reviews. These studies monitored outcomes describing episodic or acute changes, tracking measurements such as the time intervals to a change in the vomiting outcome and the self-reported severity of nausea in study participants.

Regulatory analyses have described a short-term pattern related to the number of acute vomiting episodes following Modone administration in some adult and adolescent cohorts. The findings, which describe group patterns, highlight changes measured during the study period related to physical discomfort.

Evidence for Chronic Symptoms of Gastroparesis

Modone was evaluated in adults diagnosed with refractory gastroparesis, a condition marked by functional limitations. The evidence derived from this research is based on a combination of specialized study designs, including Observational Cohort Studies and Controlled Withdrawal Studies, which focused on a highly specific patient population who had failed previous treatments.

Studies explored chronic symptoms using standardized scales and also monitored functional outcomes related to systemic or functional imbalance, such as changes in the objective rate of gastric emptying via specialized testing. Observational studies reported that patients receiving Modone reported changes in their overall symptom scores over the study period. Findings varied, with some cohorts describing patterns of maintained symptom reporting over several months.

What is Still Uncertain About Modone's Evidence Base

Data limitations contribute to uncertainty in several areas, and findings were mixed across different indications and study groups. Specifically, comparative evidence is lacking in some contexts, meaning that robust head-to-head trials against other available treatments are not broadly available. Furthermore, comprehensive long-term outcomes are not fully established or uniformly documented across all populations. The applicability of the data to general patient populations, especially those outside of the stringent criteria used in clinical trials, is an area where more research is needed.

Frequently Asked Questions (FAQ)

Common questions about Modone (FAQ)

Q: Is Modone the same kind of drug as similar medicines I've heard about?

A: Modone is officially classified as a Dopamine Antagonist. Regulatory documents describe it as peripherally selective, meaning its primary action is outside the brain, focusing on the gut and the vomiting center to manage symptoms. This peripheral focus is the key way it is described in official product monographs.

Q: How quickly can someone expect Modone to start having an effect?

A: Regulatory information based on pharmacokinetic studies indicates that the active substance is generally absorbed quickly after being taken orally. Data shows that mean peak concentrations in the body are typically reached within 0.6 to 1.2 hours.

Q: Are there any common over-the-counter pain relievers that interact with Modone?

A: Official warnings focus on combining the medicine with other drugs that can affect heart rhythm (known as QT interval) or those that inhibit certain metabolic enzymes (CYP3A4 inhibitors). These warnings do not specifically list common over-the-counter pain relievers like ibuprofen or acetaminophen, but patients are advised to check all combinations with their healthcare provider.

Q: Is it true that Modone needs to be taken at the exact same time every day?

A: Regulatory guidance recommends taking the medication up to three times a day and advises that there should be an interval of at least 8 hours between each dose. This schedule is recommended to help maintain stable drug levels and minimize risks, with official sources emphasizing the interval between doses.

Q: Why do some people say they feel tired when they start taking Modone?

A: Common adverse events reported in clinical studies include headache and dizziness. These central nervous system effects, such as dizziness, are common adverse reactions reported in studies.

Q: What is the risk of having a serious side effect with Modone?

A: Regulatory agencies have identified that Modone carries a small increased risk of serious cardiac side effects, such as irregular heartbeat. Official warnings state this risk is higher in patients over 60 years of age or when the daily oral dose is more than 30 mg.

Q: Does Modone interact with herbal supplements like St. John's Wort?

A: Official warnings prohibit combining the drug with potent CYP3A4 inhibitors (medicines that slow down the drug's breakdown). While herbal supplements are often not explicitly detailed, certain products like St. John's Wort are known to affect drug metabolism, and patients are advised to check with a healthcare professional regarding all co-administered supplements.

Q: If Modone is working, how long do official guidelines suggest I should continue taking it?

A: Official guidance states that treatment should be used for the shortest possible time at the lowest effective dose. The maximum treatment duration, according to these guidelines, should not usually exceed one week.

Q: Can Modone be split or crushed, according to the official product information?

A: Official guidance requires that standard Modone tablets must be swallowed whole with a drink of water. Patients are advised that the product information does not recommend crushing or chewing the tablets.

Q: Do food or certain drinks change how Modone is absorbed?

A: Official guidance generally suggests that the medicine should be taken 15 to 30 minutes before a meal or snack. Regulatory sources also advise checking for potential interactions with certain foods, such as grapefruit juice.

Q: Is Modone available as a generic version?

A: The active substance is domperidone, which is the generic name. It is commonly marketed globally under various brand names and is also available as a generic version, depending on the region.

Q: Are there any specific diet restrictions associated with Modone?

A: Regulatory sources advise patients to check for potential interactions with specific drinks, such as grapefruit juice. Additionally, the medicine is typically suggested to be taken before a meal for optimal absorption.

Q: How does Modone compare to placebos in research studies?

A: Research reviewed by regulatory bodies found that a placebo-controlled study in children with acute gastroenteritis did not show Modone to be more effective than placebo at relieving nausea and vomiting symptoms.

Q: Can I drive or operate machinery while using Modone, based on safety data?

A: Official guidance warns that effects like drowsiness or dizziness may impair the ability to safely drive or operate machinery. Patients experiencing these effects should exercise caution.

Q: Are there any specific laboratory tests that might be needed while taking Modone?

A: The drug is contraindicated in patients with existing cardiac conduction abnormalities. Conditions related to the heart may involve heart function monitoring, like an ECG, but routine testing is not mandated for all patients.

Q: What is the general timeline for Modone to leave the body after stopping use?

A: Pharmacokinetic studies describe the mean elimination half-life (the time it takes for half the amount of drug to be cleared) as typically ranging from 12.6 to 16.0 hours.

Q: Do regulatory agencies have specific warnings about combining Modone with other psychiatric medications?

A: Regulatory warnings strictly prohibit co-administration with other medicines that are known to prolong the QTc interval or are potent CYP3A4 inhibitors. Due to this, patients are advised to provide a full list of all medications to their prescribing healthcare professional.

Q: Why is Modone only available by prescription?

A: The drug is classified as prescription-only due to the identified risk of serious cardiac side effects, including arrhythmias and sudden cardiac death. This classification ensures the drug is only used under the supervision of a healthcare professional who can manage this risk.

Q: What are the typical ingredients found in a Modone tablet besides the active substance?

A: The active substance is domperidone base (or maleate). The other components are known as excipients, which are used to form the tablet. These often include ingredients like lactose monohydrate.

Q: Does Modone interact with birth control pills?

A: Official drug labels generally do not list this interaction directly. However, caution is sometimes advised with hormonal medicines due to the drug's known action of increasing prolactin levels in the body.

Q: Do the official documents mention any risk of withdrawal symptoms if Modone is stopped suddenly?

A: Health agencies advise against abruptly stopping the medication. They recommend a slow tapering because sudden discontinuation has been associated with symptoms such as anxiety, insomnia, agitation, depression, or panic attacks.

Q: What is the meaning of the warning label on Modone packaging?

A: The warning label is included to draw attention to the most significant safety concerns associated with the drug. For Modone, this warning centers on the increased risk of serious ventricular arrhythmias and sudden cardiac death.

Q: What is the expected duration of treatment with Modone?

A: Official regulatory guidance states that the treatment duration should not usually exceed one week. The medicine should be used for the shortest possible time at the lowest effective dose.

Q: Do different strengths of Modone exist?

A: Official product information confirms that the tablets are commonly available in a 10 mg strength in various regions.

Q: Are there warnings about Modone use in patients with a history of seizures?

A: Official warnings state that a seizure or fit while taking the medication is an adverse event that requires immediate medical attention. This information is included in the safety documentation.

Q: What regulatory agency approved Modone?

A: The product is approved by the European Medicines Agency (EMA) and various national health agencies worldwide. It is important to note that it is not approved for commercial use by the FDA in the U.S.

Q: Why does the official documentation describe specific storage requirements for Modone?

A: Official documents describe specific storage requirements, such as protecting the medicine from light and moisture, and keeping the container tightly closed. These requirements are in place to ensure the drug's stability and to prevent its degradation over time.

How should Modone be stored and disposed of?

How to Store and Dispose of Modone (Domperidone)

Official regulatory documents require Modone (Domperidone) to be stored under specific conditions to maintain stability and prevent misuse.

Storage Requirements

Modone must be stored at room temperature, generally between 15 C and 30 C, and must not be frozen or refrigerated. The medicine must be kept in its original package with the container tightly closed to protect it from light and moisture.

Classification Requirement
Temperature Do not exceed 30 C
Protection Keep tightly closed; protect from light/moisture
Child Safety Keep out of the sight and reach of children

Disposal Instructions

Unused or expired Modone must not be thrown away in household waste or emptied into drains. Patients are required to ask a pharmacist or use a take-back program for proper disposal, ensuring the medicine is discarded to an approved waste facility.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Modone found in:

A-Z Index: